Home > National Drug Code (NDC) > Concept DHA

Concept DHA - 52747-621-30 - (Vitamin- Mineral Omega-3 Supplement)

Alphabetical Index


Drug Information of Concept DHA

Product NDC: 52747-621
Proprietary Name: Concept DHA
Non Proprietary Name: Vitamin- Mineral Omega-3 Supplement
Active Ingredient(s): 25; 300; 5; 2; 12.5; 53.5; 1; 38; 5; 1.8; 200; 25; 3; 2; 10    mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1 & nbsp;   Vitamin- Mineral Omega-3 Supplement
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, LIQUID FILLED
Coding System: National Drug Codes(NDC)

Labeler Information of Concept DHA

Product NDC: 52747-621
Labeler Name: US Pharmaceutical Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date: 20090624

Package Information of Concept DHA

Package NDC: 52747-621-30
Package Description: 30 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (52747-621-30)

NDC Information of Concept DHA

NDC Code 52747-621-30
Proprietary Name Concept DHA
Package Description 30 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (52747-621-30)
Product NDC 52747-621
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Vitamin- Mineral Omega-3 Supplement
Dosage Form Name CAPSULE, LIQUID FILLED
Route Name ORAL
Start Marketing Date 20090624
Marketing Category Name UNAPPROVED DRUG OTHER
Labeler Name US Pharmaceutical Corporation
Substance Name ASCORBIC ACID; BIOTIN; CALCIUM PANTOTHENATE; CUPRIC SULFATE; CYANOCOBALAMIN; FERROUS FUMARATE; FOLIC ACID; IRON; MAGNESIUM SULFATE; NIACIN; OMEGA-3-ACID ETHYL ESTERS; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE MONONITRATE; ZINC SULFATE
Strength Number 25; 300; 5; 2; 12.5; 53.5; 1; 38; 5; 1.8; 200; 25; 3; 2; 10
Strength Unit mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1
Pharmaceutical Classes Nicotinic Acid [EPC],Nicotinic Acids [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Copper [Chemical/Ingredient],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE]

Complete Information of Concept DHA


General Information